J. Angel

发表

Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota

J. Routy, A. Marette, I. Kema, 2020, Open forum infectious diseases.

Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection.

M. Opravil, J. Angel, G. Fätkenheuer, 2008, The Journal of infectious diseases.

cIAP1/2–TRAF2–SHP-1–Src–MyD88 Complex Regulates Lipopolysaccharide-Induced IL-27 Production through NF-κB Activation in Human Macrophages

Ashok Kumar, A. Busca, J. Angel, 2018, The Journal of Immunology.

Association of the Frequency of Respiratory Illness in Early Childhood with a Change in the Distribution of Blood Lymphocyte Subpopulations

J. Karsh, R. Dales, S. Judek, 2005, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?

J. Angel, C. Costiniuk, Jonathan B. Angel, 2012, Mucosal Immunology.

Circulating endothelial progenitor cell levels are not reduced in HIV-infected men.

C. Kovacs, B. Hibbert, J. Angel, 2012, The Journal of infectious diseases.

Circulating endothelial progenitor cells in HIV infection: a systematic review.

T. Simard, B. Hibbert, J. Angel, 2013, Trends in cardiovascular medicine.

Identification of novel genes involved in apoptosis of HIV-infected macrophages using unbiased genome-wide screening

F. Vizeacoumar, Ashok Kumar, F. Vizeacoumar, 2021, BMC Infectious Diseases.

Salivary testing of COVID-19: evaluation of serological testing following positive salivary results

S. Johnson-Obaseki, L. Caulley, J. Angel, 2021, BMC Infectious Diseases.

Expression of γ‐chain cytokine receptors on CD8+ T cells in HIV infection with a focus on IL‐7Rα (CD127)

J. Angel, A. Crawley, 2012, Immunology and cell biology.

Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages

R. Korneluk, J. Angel, W. Cameron, 2021, Scientific Reports.

Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice

J. Mcbane, J. Angel, Seung-Hwan Lee, 2021, Immunity, inflammation and disease.

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent

J. Angel, T. Berthoud, Nawaf Aloufi, 2021, ImmunoTargets and therapy.

Jak/STAT and PI3K signaling pathways have both common and distinct roles in IL‐7‐mediated activities in human CD8+ T cells

Ashok Kumar, A. Busca, J. Angel, 2014, Journal of leukocyte biology.

Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection

E. Mills, J. Angel, C. Cooper, 2007, AIDS.

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol

M. Ostrowski, J. Routy, S. Isnard, 2019, BMJ Open.

Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173)

C. Tremblay, J. Routy, K. Corace, 2010, AIDS care.

Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae

Guangshun Wang, N. Tanphaichitr, J. Angel, 2018, Human reproduction.

Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease

J. Angel, C. Cooper, A. Crawley, 2019, Front. Immunol..

Remodeling of the plasma membrane in preparation for sperm–egg recognition: roles of acrosomal proteins

R. Aitken, J. Whitelegge, N. Tanphaichitr, 2015, Asian journal of andrology.

External Quality Assessment of HLA-B*5701 Reporting: An International Multicentre Survey

S. Mallal, M. Gill, C. Mamotte, 2007, Antiviral therapy.

Willingness of older Canadians with HIV to participate in HIV cure research near and after the end-of-life: A mixed-method study.

M. Ostrowski, C. Kovacs, J. Routy, 2022, AIDS research and human retroviruses.

Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications.

J. Angel, C. Hughes, A. Tseng, 2019, The Canadian journal of cardiology.

Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions

M. Ofner, J. Angel, J. Brooks, 2013, BMC Infectious Diseases.

HIV Knowledge Among Canadian-Born and Sub-Saharan African-Born Patients Living with HIV

H. Tulloch, G. Garber, J. Angel, 2012, Journal of Immigrant and Minority Health.

Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV‐infected patients receiving antiretroviral therapy

J. Singer, J. Routy, D. Radzioch, 2015, HIV medicine.

CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.

J. Angel, H. Davis, C. Cooper, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

IL-2 receptor γ chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127− T cell division and susceptibility to apoptosis

J. Angel, A. Crawley, T. Katz, 2008, International immunology.

and susceptibility to apoptosis

J. Angel, A. Crawley, T. Katz, 2008 .

Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.

J. Angel, Teslin S Sandstrom, N. Ranganath, 2017, Cytokine & growth factor reviews.

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection

J. Tschopp, Ashok Kumar, A. Badley, 1999, Cell Death and Differentiation.

Medical Assistance in Death as a Unique Opportunity to Advance HIV Cure Research.

J. Angel, Stephanie C. Burke Schinkel, Teslin S Sandstrom, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review

S. Doucette, D. Fergusson, J. Angel, 2011, PloS one.

IL‐7‐dependent STAT‐5 activation and CD8+ T cell proliferation are impaired in HIV infection

J. Angel, A. Crawley, Agatha Vranjkovic, 2011, Journal of leukocyte biology.

IL-7 decreases IL-7 receptor a (CD127) expression and induces the shedding of CD127 by human

Ashok Kumar, K. Gee, J. Angel, 2007 .

IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells.

Ashok Kumar, K. Gee, J. Angel, 2007, International immunology.

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

L. Shapiro, C. Dinarello, S. Wolff, 1995, Journal of immunology.

Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10

Ashok Kumar, D. Creery, J. Angel, 2002, Clinical and Vaccine Immunology.

Interleukin-10 through Differential Utilization of Expression of CD 14 on Human Monocytes Virus and Lipopolysaccharide Induce Nef Protein of Human Immunodeficiency

William, D. Creery, J. Angel, 2002 .

Retinoids: novel potential therapeutics in the pursuit of HIV-1 cure

J. Angel, M. McGuinty, B. Vulesevic, 2022, Frontiers in Virology.

Interleukin‐4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells

J. Angel, C. Young, A. Crawley, 2010, European journal of immunology.

Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.

K. Wright, S. Aaron, R. Dales, 2001, American journal of respiratory and critical care medicine.

IFN-γ-induced IL-27 and IL-27p28 expression are differentially regulated through JNK MAPK and PI3K pathways independent of Jak/STAT in human monocytic cells.

Ashok Kumar, J. Angel, M. Kozlowski, 2014, Immunobiology.

The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patients.

J. Angel, K. Woodend, M. J. Turner, 2004, HIV clinical trials.

Liver toxicity resulting from syphilis and Jarish-Herxheimer reaction in cases of coinfection with HIV and hepatitis C virus.

J. Angel, C. Cooper, P. Macpherson, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cardiovascular complications of Salmonella enteritidis infection.

C. Dennie, T. Simard, B. Hibbert, 2010, The Canadian journal of cardiology.

LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy

J. Routy, J. Goulet, M. Massanella, 2021, EBioMedicine.

An In vitro Model for the Study of HIV Infection of Thymocytes

J. Angel, C. Young, 2013 .

IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation

Ashok Kumar, J. Angel, T. Berthoud, 2017, PloS one.

Down‐regulation of CXCR‐4 and CCR‐5 expression by interferon‐γ is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes

A. Kumar, D. Creery, J. Angel, 2004, Clinical and experimental immunology.

A Phase I Study of Interleukin-10 in Healthy Humans: Safety and Effects on Cytokine Production

L. Shapiro, C. Dinarello, S. Wolff, 1995 .

A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects

M. Jacobson, L. Shapiro, J. Angel, 2000, AIDS.

CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection

J. Angel, J. Clinch, H. Davis, 2008, Journal of immune based therapies and vaccines.

Soluble IL-7Rα (sCD127) Inhibits IL-7 Activity and Is Increased in HIV Infection

J. Angel, S. Faucher, A. Crawley, 2010, The Journal of Immunology.

A meta‐analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir‐boosted protease inhibitor maintenance therapy in HIV‐infected adults with established virological suppression after induction

B. Conway, J. Angel, J. Baril, 2014, HIV medicine.

Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelines.

M. Wainberg, C. Tremblay, A. Rachlis, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expression.

J. Angel, K. A. Chambers, K. Parato, 2002, Cellular immunology.

Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.

C. Dinarello, J. Angel, P. Skolnik, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10

Ashok Kumar, A. Badley, J. Angel, 2002, AIDS.

HIV infection of thymocytes inhibits IL-7 activity without altering CD127 expression

J. Angel, C. Young, 2011, Retrovirology.

Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes.

Ashok Kumar, D. Creery, J. Angel, 2006, Viral immunology.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, R. Hogg, 2017, BMC Research Notes.

Development of a Quantitative Bead Capture Assay for Soluble IL-7 Receptor Alpha in Human Plasma

J. Angel, P. Sandstrom, M. Bergeron, 2009, PloS one.

HIV-Infected Macrophages Are Infected and Killed by the Interferon-Sensitive Rhabdovirus MG1

J. Angel, C. Costiniuk, M. Jenabian, 2021, Journal of Virology.

Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.

J. Angel, A. Kempinska, E. Kwak, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Proteomic Characterization of Pig Sperm Anterior Head Plasma Membrane Reveals Roles of Acrosomal Proteins in ZP3 Binding

R. Aitken, J. Whitelegge, N. Tanphaichitr, 2015, Journal of cellular physiology.

Protease inhibitors and adipocyte differentiation in cell culture

A. Sorisky, A. Gagnon, J. Angel, 1998, The Lancet.

Type I interferon responses are impaired in latently HIV infected cells

J. Angel, S. Fadel, Sandra C. Côté, 2016, Retrovirology.

Reply to: Cardiovascular Disease Risk in HIV Infection and Endothelial Progenitor Cells

B. Hibbert, J. Angel, C. Costiniuk, 2012 .

Correspondence Reply to: Cardiovascular Disease Risk in HIV Infection and Endothelial Progenitor

B. Hibbert, J. Angel, C. Costiniuk, 2012 .

Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy.

J. Angel, P. Macpherson, N. Hawley-Foss, 2001, Journal of acquired immune deficiency syndromes.

Salivary testing for SARS-CoV-2 in the pediatric population: a diagnostic accuracy study

S. Johnson-Obaseki, D. Champredon, R. Milwid, 2022, CMAJ open.

Characteristics of hepatitis C virus infection in HIV-infected people.

A. Badley, J. Angel, C. Cooper, 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo.

A. Badley, J. Angel, J. Lum, 2004, Frontiers in bioscience : a journal and virtual library.

Dexamethasone Inhibits IL-12p40 Production in Lipopolysaccharide-Stimulated Human Monocytic Cells by Down-Regulating the Activity of c-Jun N-Terminal Kinase, the Activation Protein-1, and NF-κB Transcription Factors1

Ashok Kumar, K. Gee, Wei Ma, 2004, The Journal of Immunology.

Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV‐1 replication

T. Greten, C. Dinarello, S. Endres, 1995, AIDS.

A Latent Class Analysis of the Social Determinants of Health Impacting Heavy Alcohol Consumption Among Women Living with HIV in Canada: The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, A. Burchell, 2019, AIDS and Behavior.

Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.

A. Badley, J. Angel, S. Cassol, 2000, AIDS research and human retroviruses.

Sperm can act as vectors for HIV‐1 transmission into vaginal and cervical epithelial cells

N. Tanphaichitr, F. Compostella, J. Angel, 2019, American journal of reproductive immunology.

Acute monoarthritis complicating therapy with indinavir.

G. Garber, J. Angel, K. Gallicano, 2000, AIDS.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial.

P. Messiaen, E. Adachi, J. Angel, 2023, AIDS patient care and STDs.

Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

R Rode, M Salgo, D. Ho, 1999, AIDS.

Pharmacokinetics of 3TC (GR109714X) Administered With and Without Food to HIV-infected Patients

J. Montaner, J. Ruedy, J. McCormack, 1993 .

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

D. Podzamczer, B. Clotet, H. Stellbrink, 2017, The Lancet.

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

S. Trottier, B. Conway, M. Loutfy, 2013, BMC Infectious Diseases.

An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus Nicotine Replacement Therapy

A. Pipe, G. Garber, J. Angel, 2017, AIDS care.

ALVAC-HIV as a prophylactic and therapeutic vaccine: highlights from over a decade of clinical trials

J. Angel, C. Costiniuk, 2011 .

Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression.

A. Badley, A. Kumar, J. Angel, 2001, The Journal of infectious diseases.

Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/μl when viral replication is suppressed

G. D’Egidio, D. Fergusson, J. Angel, 2007, AIDS.

Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir.

J. Leonard, A. Kumar, J. Angel, 1998, The Journal of infectious diseases.

Virologic and immunologic activity of PegIntron in HIV disease

D. Ward, J. Angel, W. Greaves, 2009, AIDS.

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults

J. Angel, A. Krieg, H. Davis, 2005, AIDS.

SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)

A. Anis, J. Angel, Z. Brumme, 2023, Viruses.

Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells

G. Bren, A. Badley, J. Angel, 2010, PLoS pathogens.

Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus.

J. Angel, C. Cooper, M. A. Parbhakar, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancy.

J. Angel, K. Gallicano, Y. Khaliq, 2001, AIDS.

Long-Term Follow-up of a Cohort of HIV-Infected Patients Who Discontinued Maintenance Therapy for Cytomegalovirus Retinitis

J. Raboud, S. Walmsley, A. Rachlis, 2006, HIV clinical trials.

Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection

J. Angel, P. Brown, 2005, Journal of immune based therapies and vaccines.

Cyclosporin A and FK506 Inhibit IL-12p40 Production through the Calmodulin/Calmodulin-dependent Protein Kinase-activated Phosphoinositide 3-Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells*

N. Reiner, Ashok Kumar, K. Gee, 2007, Journal of Biological Chemistry.

Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome

A. Komaroff, J. Cannon, S. Wolff, 1997, Journal of Clinical Immunology.

Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

David S. Park, R. Padmore, D. Philpott, 2011, Journal of Neural Transmission.

Acute Phase Responses and Cytokine Secretion in Chronic Fatigue Syndrome

R. W. Ball, A. Komaroff, J. Cannon, 2004, Journal of Clinical Immunology.

Interleukin‐7 enhances memory CD8+ T‐cell recall responses in health but its activity is impaired in human immunodeficiency virus infection

J. Angel, A. Crawley, Alison M. O’Connor, 2010, Immunology.

HIV-1 Nef Inhibits Lipopolysaccharide-induced IL-12p40 Expression by Inhibiting JNK-activated NFκB in Human Monocytic Cells*

Ashok Kumar, Wei Ma, J. Angel, 2009, Journal of Biological Chemistry.

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

S. Trottier, J. Singer, C. Kovacs, 2016, Scientific Reports.

Social Determinants of Health and Retention in HIV Care Among Recently Incarcerated Women Living with HIV in Canada

S. Trottier, T. Hart, R. Hogg, 2019, AIDS and Behavior.

Hormonal Influences on Stress-Induced Neutrophil Mobilization in Health and Chronic Fatigue Syndrome

A. Komaroff, J. Cannon, J. O'grady, 1998, Journal of Clinical Immunology.

SMAC Mimetics as Therapeutic Agents in HIV Infection

Arunandan Kumar, J. Angel, Bengisu Molyer, 2021, Frontiers in Immunology.

Complexed soluble IL-7 receptor α and IL-7 increase IL-7-mediated proliferation and viability of CD8⁺ T-cells in vitro.

S. Sad, J. Angel, A. Crawley, 2015, Cellular immunology.

The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure

J. Angel, Stephanie C. Burke Schinkel, Sandra C. Côté, 2017, The Journal of infectious diseases.

Continue Antiretroviral Therapy during Virologic Failure?

J. Angel, J. Lum, A. Pilon, 2010 .

The Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy)

C. Tremblay, J. Routy, J. Angel, 2015, Journal of acquired immune deficiency syndromes.

A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune

J. Singer, C. Kovacs, C. Tremblay, 2011, AIDS.

Surreptitious antiretroviral use as an explanation for apparent elite HIV control.

J. Angel, C. Costiniuk, C. L. la Porte, 2012, AIDS patient care and STDs.

Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation

Michael Y. Li, B. Gelman, C. Power, 2021, mBio.

Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study

T. Hart, M. Loutfy, J. Raboud, 2009, PloS one.

The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada

T. Hart, M. Loutfy, L. Serghides, 2013, AIDS care.

Activation Protein-1 , and NF-Activity of c-Jun N-Terminal Kinase , the Monocytic Cells by Down-Regulating the in Lipopolysaccharide-Stimulated Human Dexamethasone Inhibits IL-12 p 40 Production

K. Gee, J. Angel, M. Kozlowski, 2003 .

Inhibitor of apoptosis, IAP, genes play a critical role in the survival of HIV-infected macrophages

M. Tremblay, Ashok Kumar, R. Korneluk, 2019, bioRxiv.

Intracellular HIV-Tat Expression Induces IL-10 Synthesis by the CREB-1 Transcription Factor through Ser133 Phosphorylation and Its Regulation by the ERK1/2 MAPK in Human Monocytic Cells*

Ashok Kumar, K. Gee, Wei Ma, 2006, Journal of Biological Chemistry.

Cervical cancer screening among HIV-positive women

K. Pottie, J. Angel, C. Kendall, 2010 .

Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic.

K. Pottie, J. Angel, C. Kendall, 2010, Canadian family physician Medecin de famille canadien.

Comparison of interferon‐γ‐, interleukin (IL)‐17‐ and IL‐22‐expressing CD4 T cells, IL‐22‐expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection

A. Kumar, J. Angel, L. Filion, 2012, Clinical and experimental immunology.

The Clinician Investigator Program at the University of Ottawa

J. Angel, 2014 .

Selective killing of human M1 macrophages by Smac mimetics alone and M2 macrophages by Smac mimetics and caspase inhibition

Ashok Kumar, J. Angel, Duale Ahmed, 2021, Journal of leukocyte biology.

PI3K/Akt regulates survival during differentiation of human macrophages by maintaining NF‐κB‐dependent expression of antiapoptotic Bcl‐xL

Ashok Kumar, A. Busca, J. Angel, 2014, Journal of leukocyte biology.

Design and Implementation of a Randomized Crossover Study of Valproic Acid and Antiretroviral Therapy to Reduce the HIV Reservoir

S. Trottier, J. Singer, C. Tremblay, 2012, HIV clinical trials.

Engagement of CD14 sensitizes primary monocytes to IFN-γ to produce IL-12/23p40 and IL-23 through p38 mitogen-activated protein kinase and independent of the janus kinase/signal transducers and activators of transcription signaling.

J. Angel, M. Kozlowski, Niranjala Gajanayaka, 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Selective Induction of Cell Death in Human M1 Macrophages by Smac Mimetics Is Mediated by cIAP-2 and RIPK-1/3 through the Activation of mTORC

J. Angel, Niranjala Gajanayaka, Ashok Kumar, 2021, The Journal of Immunology.

TLR-4 Agonist Induces IFN-γ Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR– and JNK-MAPK–Activated p70S6K Pathway

J. Angel, A. Mookerjee, D. Cameron, 2021, The Journal of Immunology.

Optimization of culture and storage conditions for an in vitro system to evaluate thymocyte phenotype and function.

J. Angel, C. Young, 2006, Journal of immunological methods.

Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions

J. Angel, Gina M. Graziani, 2015, Journal of the International AIDS Society.

Successful implementation of a national HLA-B*5701 genetic testing service in Canada.

M. Gill, A. Rachlis, J. Angel, 2010, Tissue antigens.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, R. Hogg, 2017, BMC Research Notes.

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

M. Gill, P. Cahn, S. Walmsley, 2016, PloS one.

Development and psychometric validation of the HIV Treatment Knowledge Scale

G. Garber, J. Angel, G. Tasca, 2007, AIDS care.

Short communication: human immunodeficiency virus rebound in blood and seminal plasma following discontinuation of antiretroviral therapy.

J. Singer, C. Kovacs, J. Routy, 2012, AIDS research and human retroviruses.

Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices.

Sandra M Houston, G. Garber, J. Angel, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART

G. Garber, J. Angel, G. Tasca, 2006, AIDS care.

Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis

A. Sorisky, A. Gagnon, J. Angel, 2000, AIDS.

Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptions.

A. Badley, G. Garber, J. Angel, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression

J. Angel, F. Rhame, S. Deresinski, 2000 .

IL-10 Regulation by HIV-Tat in Primary Human Monocytic Cells: Involvement of Calmodulin/Calmodulin-Dependent Protein Kinase-Activated p38 MAPK and Sp-1 and CREB-1 Transcription Factors1

Ashok Kumar, K. Gee, J. Angel, 2007, The Journal of Immunology.

CREB-1 Transcription Factors Kinase-Activated p 38 MAPK and Sp-1 and Calmodulin / Calmodulin-Dependent Protein Human Monocytic Cells : Involvement of IL-10 Regulation by HIV-Tat in Primary Blahoianu and

K. Gee, J. Angel, Sasmita Mishra, 2006 .

COVID-19 vaccine immunogenicity in people with HIV

A. Burchell, M. Ostrowski, C. Kovacs, 2022, AIDS.

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

J. Singer, A. Burchell, M. Ostrowski, 2021, BMJ Open.

Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use.

J. Angel, B. Toye, R. McKendry, 2005, Diagnostic microbiology and infectious disease.

Causes of death of HIV-infected persons in Ottawa, Ontario, 1984-1995.

G. Garber, J. Angel, S. Kravcik, 1997, Archives of internal medicine.

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

J. Routy, D. Margolis, D. Asmuth, 2016, Journal of acquired immune deficiency syndromes.

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

J. Angel, S. Kravcik, V. Roth, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy.

A. Badley, G. Garber, J. Angel, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV and HIV‐Tat inhibit LPS‐induced IL‐27 production in human macrophages by distinct intracellular signaling pathways

Ashok Kumar, J. Angel, S. O’Hara, 2017, Journal of leukocyte biology.

Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception

M. Loutfy, L. Serghides, S. Walmsley, 2017, Journal of the International Association of Providers of AIDS Care.

Clinical, hematologic, and immunologic effects of interleukin-10 in humans

Edouard Vannier, L. Shapiro, C. Dinarello, 1996, Journal of Clinical Immunology.

HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine

J. Angel, Gina M. Graziani, 2016, Expert opinion on biological therapy.

Salivary Detection of COVID-19

S. Johnson-Obaseki, L. Eapen, N. Bastien, 2020, Annals of Internal Medicine.

Early Changes in T-Cell Activation Predict Antiretroviral Success in Salvage Therapy of HIV Infection

C. Kovacs, M. Loutfy, J. Raboud, 2008, Journal of acquired immune deficiency syndromes.

Disruption of MAP kinase activation and nuclear factor binding to the IL‐12 p40 promoter in HIV‐infected myeloid cells

R. Parks, J. Angel, K. A. Chambers, 2004, Clinical and experimental immunology.

Effects of Highly Active Antiretroviral Therapy and Immune Recovery on CD8+ T-Cell-Mediated Inhibition of HIV-1 Transcription

J. Angel, K. Copeland, Bilge Diker, 2006, Journal of acquired immune deficiency syndromes.

Virological evaluation of the ‘Ottawa case’ indicates no evidence for HIV-1 superinfection

B. Branson, R. Grant, E. Delwart, 2004, AIDS.

Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group.

J. Angel, F. Rhame, S. Deresinski, 2000, AIDS.

Correction: IL-10 Regulation by HIV-Tat in Primary Human Monocytic Cells: Involvement of Calmodulin/Calmodulin-Dependent Protein Kinase-Activated p38 MAPK and Sp-1 and CREB-1 Transcription Factors

Ashok Kumar, K. Gee, J. Angel, 2012, The Journal of Immunology.

Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults.

A. Rachlis, J. Angel, M. Harris, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Disparate regulation of LPS-induced MAPK signaling and IL-12p40 expression between different myeloid cell types with and without HIV infection.

A. Busca, R. Parks, Wei Ma, 2010, Viral immunology.

Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia.

J. Angel, S. Kravcik, J. Chan, 1999, Journal of acquired immune deficiency syndromes.

Type I interferon responses are impaired in latently HIV infected cells

J. Angel, S. Fadel, Sandra C. Côté, 2016, Retrovirology.

Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity

Ashok Kumar, Nancy Tremblay, S. Byrareddy, 2020, BMJ Open.

Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential

T. Hart, M. Loutfy, J. Raboud, 2014, Journal of the International Association of Providers of AIDS Care.

DEVELOPMENT OF KAPOSI'S SARCOMA DESPITE SUSTAINED SUPPRESSION OF HIV PLASMA VIREMIA

J. Angel, S. Kravcik, J. Chan, 1999 .

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients.

C. Tremblay, S. Walmsley, A. Rachlis, 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

The influence of HIV on CD127 expression and its potential implications for IL-7 therapy.

J. Angel, Jonathan B Angel, Angela M Crawley, 2012, Seminars in immunology.

17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae.

R. Kaul, Guangshun Wang, N. Tanphaichitr, 2022, Human reproduction.

IL‐7 induces sCD127 release and mCD127 downregulation in human CD8+ T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection

J. Angel, T. Berthoud, A. Crawley, 2019, European journal of immunology.

Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome.

A. Komaroff, J. Cannon, S. Wolff, 1997, Journal of Clinical Immunology.

Title Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA : A randomized , double-blind , placebo-controlled clinical trial Permalink

J. Routy, D. Margolis, D. Asmuth, 2022 .

Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta.

A. Kumar, D. Kumar, J. Angel, 1999, AIDS research and human retroviruses.

In vitro HIV Type 1 infection indirectly alters CD127 expression on CD8(+) T cells.

J. Angel, A. Crawley, Agatha Vranjkovic, 2012, AIDS research and human retroviruses.

Optimizing the efficiency of therapeutic HIV vaccine trials: A case for CTN 173

J. Singer, C. Tremblay, J. Routy, 2012 .

The effect of human immunodeficiency virus‐1 on monocyte‐derived dendritic cell maturation and function

J. Angel, J. Angel, P. Fairman, 2012, Clinical and experimental immunology.

Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.

C. Dinarello, J. Angel, P. Skolnik, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Development and Validation of the HIV Medication Readiness Scale

K. Corace, G. Garber, J. Angel, 2007, Assessment.

Interactions between protease inhibitors and acid‐reducing agents: a systematic review

J. Angel, J. Angel, C. Porte, 2007, HIV medicine.

Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.

J. Angel, 2001, The AIDS reader.

Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects.

M. Jacobson, L. Shapiro, C. Dinarello, 2007, European cytokine network.

Impact of in vitro HIV infection on human thymic regulatory T cell differentiation

J. Angel, Omar Farnós, T. Scorza, 2023, Frontiers in microbiology.

The influence of HIV on CD127 expression and its potential implications for IL-7 therapy.

J. Angel, A. Crawley, 2012, Seminars in immunology.

HIV-1 Nef Inhibits Lipopolysaccharide-induced IL-12p40 Expression by Inhibiting JNK-activated NFκB in Human Monocytic Cells*

N. Reiner, Ashok Kumar, K. Gee, 2007, Journal of Biological Chemistry.

Expression of γ‐chain cytokine receptors on CD8+ T cells in HIV infection with a focus on IL‐7Rα (CD127)

J. Angel, A. Crawley, 2012, Immunology and cell biology.

Journal of Immune Based Therapies and Vaccines Cpg Increases Vaccine Antigen-specific Cell-mediated Immunity When Administered with Hepatitis B Vaccine in Hiv Infection

J. Angel, J. Clinch, H. Davis, 2022 .